Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aditxt Inc ADTX

Healthcare Biotechnology
Aditxt, Inc. is a biotech company focused on discovering, developing, and deploying health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc... see more

Recent & Breaking News (NDAQ:ADTX)

Aditxt Announces Pricing of $11.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Business Wire August 26, 2021

Aditxt, Inc. Signs Letter of Intent for Exclusive Rights to Negotiate the Acquisition of a Biopharmaceutical Company Commercializing and Distributing Antiviral Oral Therapy for COVID-19

Business Wire August 25, 2021

Aditxt, Inc. and Great Lakes Medical Laboratory Launch AditxtScore for COVID-19 in State of Michigan as a Personalized Approach to Addressing COVID-19 Pandemic

Business Wire August 11, 2021

Aditxt Provides Update on AditxtReprogramming's(TM) Apoptotic DNA Immunotherapy Therapeutic Platform

Business Wire August 4, 2021

Aditxt Launches High-Sensitivity Neutralizing Antibody Test to Detect Individual Immune Response to COVID-19

Business Wire July 12, 2021

Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA

Business Wire July 7, 2021

Aditxt Announces the Appointment of Dr. Lauren Chung to its Board of Directors

Business Wire June 18, 2021

Aditxt Set to Join Russell Microcap® Index

PR Newswire June 15, 2021

Aditxt Signs Channel Partner Agreement with Meridian HSN to Make AditxtScore(TM) for COVID-19 Available to its Network of Healthcare Provider Partners

PR Newswire May 6, 2021

Aditxt to Establish State-of-the-Art Immune Monitoring Center in Richmond, VA

PR Newswire May 3, 2021

Aditxt Therapeutics Names Sunny Uberoi as its first Chief Communications Officer

PR Newswire April 13, 2021

HealthBar Becomes AditxtScore(TM) Channel Partner to Offer AditxtScore(TM) for COVID-19 Immunity Status Monitoring to Complement its Concierge and Drive-Thru Testing Services

PR Newswire April 6, 2021

Collection Sites, LLC Named AditxtScore(TM) Channel Partner to Offer AditxtScore(TM) for COVID-19 Immunity Status Monitoring through its Mobile Testing Centers

PR Newswire April 1, 2021

Collection Sites, LLC Named AditxtScore(TM) Channel Partner to Offer AditxtScore(TM) for COVID-19 Immunity Status Monitoring Through Its Mobile Testing Centres

GlobeNewswire April 1, 2021

Aditxt to Initiate First-In-Human Clinical Trials with its Therapeutics Programs in Psoriasis by Year-End

PR Newswire March 24, 2021

Aditxt Announces Participation in the Benzinga Biotech Small Cap Conference

Newsfile March 22, 2021

Eazy Testing Inc. Becomes AditxtScore(TM) Channel Partner, to Offer AditxtScore(TM) for COVID-19 Immunity Status Monitoring with its Walk-In, Concierge, and Pre-Flight Services

GlobeNewswire March 4, 2021

Immunologist and Clinical Transplant Expert, Dolly B. Tyan, PhD, Joins Aditxt as Senior VP of Clinical Development - Transplantation

GlobeNewswire January 29, 2021

Aditxt Secures $5 Million Financing to Scale AditxtScore(TM) Operational Capacity

GlobeNewswire January 26, 2021

AditxtScore(TM) Immune Monitoring Service Will be Operational on February 1st

GlobeNewswire January 21, 2021